Ophthalmology, Neuro-ophthalmology · Philadelphia, PA
NPI
1376609362
Since 2006
Specialty
Ophthalmology, Neuro-ophthalmology
Code 207WX0109X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
3801 Filbert St
Philadelphia, PA, 19104
Phone (215) 662-8100
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
800 services
Medicare patients, 2024
453
Average age 73
Drug cost, 2024
$1.8M
264 prescriptions
Company payments, 2025
$51K
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Madhura Tamhankar was code 99214 (office e&m - established), 227 times for 193 patients. In total Madhura Tamhankar billed 800 services in 18 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-04-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 227 | 193 | $63.11 | $14K |
| 99213 Office E&M - Established | Facility | 170 | 158 | $51.78 | $8,802 |
| 99204 Office E&M - New | Facility | 155 | 155 | $101.14 | $16K |
| 92083 Vision, Hearing, and Speech Services | Facility | 32 | 29 | $19.88 | $636 |
| 92250 Angiography | Facility | 13 | 13 | $15.24 | $198 |
| 99203 Office E&M - New | Facility | 13 | 13 | $66.44 | $864 |
By year: 2022 $73K for 885 services; 2023 $62K for 830 services; 2024 $51K for 800 services.
Medicare prescription drug claims, 2024
In 2024, the drug Madhura Tamhankar prescribed most often to Medicare patients was Pyridostigmine Bromide, with 51 prescriptions and refills. In total Madhura Tamhankar wrote 264 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pyridostigmine Bromide Generic | 51 | 89 | 16 | $4,094 |
| Prednisolone Acetate Generic | 32 | 34 | 20 | $1,633 |
| Prednisone Generic | 30 | 61 | Under 11 | $121 |
| Tepezza Teprotumumab-Trbw | 29 | 29 | Under 11 | $1.8M |
| Latanoprost Generic | 20 | 27 | Under 11 | $185 |
| Omeprazole Generic | 19 | 19 | Under 11 | $15.61 |
| Acetazolamide Generic | 18 | 35 | Under 11 | $1,241 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 14 | 14 | 14 | $30.85 |
| Acetazolamide Er Acetazolamide | 11 | 25 | Under 11 | $322 |
Brand drugs: 86 claims; generic drugs: 178 claims; opioid claims: 14.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Madhura Tamhankar $51K ($51K in general payments such as food, travel and fees and $621 for research) from 4 companies. The largest payer was Amgen Inc. with $28K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.